Car-T Infection Risk
Posted in Abecma Car T, Misc, Multiple Myeloma on Nov 20th, 2021
“The article discusses infection risk for the hematological malignancies for all the illnesses listed in the first paragraph but, somewhat unfortunately, to a lesser extent for MM considering the very limited patient experiences with the anti-BCMA products. Still, a number of observations and conclusions are very relevant for us, myeloma patients.”… A topical article over […]